Evidence map›Paper›PMID 41293926›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

FSTL1 Orchestrates Metabolic-Epigenetic Crosstalk: Glycolysis-Dependent H3K18 Lactylation Drives Cartilage Fibrosis in Osteoarthritis.

Feng Lu, Yunyuan Yu, Guangrong Yin, Huiqun Hu, Shishuo Li, Yuting Tang, Yimin Liu, Maoyuan Li, Liang Liang Wang, Chao Xu and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Lactate Signal: Modulator of Cellular Energy Production and Anabolism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Feng LuDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.ORCID https://orcid.org/0000-0002-5341-0746
Yunyuan YuArticular Orthopaedics, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, P. R. China.
Guangrong YinDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.
Huiqun HuDepartment of Thoracic Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, P. R. China.
Shishuo LiDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.
Yuting TangDepartment of Medical Genetics, Nanjing Medical University, Longmian Road 101, Nanjing, 211166, P. R. China.
Yimin LiuDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.
Maoyuan LiDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.
Liang Liang WangDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.
Chao XuDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.
Gongyin ZhaoDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.
Baojun ZhouDepartment of Orthopedics, The Third Affiliated Hospital of Gansu University of Chinese Medicine, 222 Silong Road, Baiyin, 730900, P. R. China.
Yuji WangDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital), Changzhou, Jiangsu, 213003, P. R. China.ORCID https://orcid.org/0000-0003-1385-7217

Funding

Clinical Research Project of Changzhou Medical Center of Nanjing Medical University CZKYCMCB202215
6 · The paper itself

Abstract

The progression of osteoarthritis (OA) is fundamentally characterized by the aberrant transformation of chondrocytes into a fibrotic phenotype, although the precise molecular mechanisms involved remain inadequately understood. In this study, the interplay between epigenetic modifications and metabolic reprogramming during the activation of fibrocartilage cells in osteoarthritis was investigated. The findings demonstrate that FSTL1 markedly upregulates key glycolytic enzymes, including LDHA, HK2, and PKM, in chondrocytes, triggering a "glycolytic burst" that results in elevated intracellular lactate levels. This accumulated lactate acts as a precursor for epigenetic modifications, specifically promoting the lactylation of histone H3 lysine 18 (H3K18la) in fibrocartilage cells, thereby facilitating the transcriptional activation of critical fibrosis-related genes such as Itga6, Cxcl10, and Parp16. Notably, pharmacological inhibition of the PI3K/mTOR pathway or lactate dehydrogenase significantly diminishes H3K18la levels and markers of chondrocyte fibrosis, while exogenous lactate supplementation can counteract this effect. In summary, this study unveils the core mechanism by which FSTL1 reshapes the epigenetic landscape of chondrocytes and drives the fibrotic process through the activation of the "glycolysis-lactate-H3K18la" cascade axis, offering a dual-target intervention strategy for OA involving metabolic reprogramming and epigenetic modification.

Indexed as

CartilageEpigenesis, GeneticFollistatin-Related ProteinsGlycolysisHistonesOsteoarthritisAnimalsChondrocytesFibrosisHumansMaleFollistatin-Related ProteinsFSTL1 protein, humanHistonescartilagefibrosisFSTL1glycolysislactylationosteoarthrosis

Identifiers

PMID41293926
PMCPMC12884748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.